BD Biosciences
Tools for stem cell biology and tissue engineering research (but also many other research-related products)
BD Biosciences is one of three business segments of BD (Becton, Dickinson and Company) offering expertise in molecular biology, cellular biology, immunology, and cell analysis. Clontech, Discovery Labware, Immunocytometry Systems, and Pharmingen are the business units of the company.
Vincent A. Forlenza, Executive Vice President
Sailaja Kuchibhatla, VP Business Development and Marketing, Clontech
2350 Qume Drive
San Jose, CA, 95131-1807
USA
Phone: +1-877-232-8995
Fax: +1-800-325-9637
The product portfolio concerning tissue engineering products includes, amongst others: Three-dimensional (3D) biodegradable scaffolds, BD™, PuraMatrix™ peptide hydrogel, extracellular matrix (ECM) and cell attachment factors, growth factors/cytokines and extracellular matrix molecules, growth factors/cytokines, and other factors used to promote stem/progenitor cell proliferation and differentiation in vitro.
Related news
- BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
- BD and Direct Relief International Launch Volunteer Service Program to Improve Healthcare in Ghana
- BD and FIND Announce Expanded Collaboration to Improve Tuberculosis Diagnostics Worldwide
- BD Move Signals Commitment to Oxford
- BD Honored as One of "America's Most Admired Companies" in FORTUNE Magazine's Annual Rankings
- BD Biosciences and Roche Collaborate to Advance the Study of Cell Signal Transduction through New Phosphorylation Site Antibody Targets and Applications
- Nationwide Seminar Series to Focus on the Role of Cell Analysis Technologies in Life Science and Pharmaceutical Research
- BD Commits $34 Million for Major Expansion in Québec
- BD Medical Creates BD FluStockSM Planning Service to Aid Pandemic Influenza Preparedness Efforts in Hospitals
- BD Announces Results of Shareholder Votes at Annual Meeting
- BD Board Declares Dividend
- BD Announces Results for First Fiscal Quarter